Human Antihemophilic Factor/Von Willebrand Factor Complex
Von Willebrand Disease (Hereditary Or Acquired)
Assiut Universityprotein_peptideUnknownActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Von Willebrand Disease (Hereditary Or Acquired) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Alphanate Sd/Ht Grifols Biologicals, LLC | Phase 4 | BB |
Factor Viii (Human) Bio Products Laboratory | Phase 3 | BB |
Interleukin-11 University of Pittsburgh | Phase 2 | B |
Oprelvekin University of Pittsburgh | Phase 2 | CCC |
Von Willebrand Factor National Center for Research Resources (NCRR) | Phase 1 | CC |
Tranexamic Acid Assiut University | Unknown | D |
Rondaptivon Pegol Sodium Medical University of Vienna | Phase 2 | NR |
Cyclokapron Mary M. Gooley Hemophilia Center | N/A | NR |
Same molecule, other indications
Human Antihemophilic Factor/Von Willebrand Factor Complex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →